Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Susan T. Hubbard | F | - | 8 years | |
| Julie Smith | F | 53 | 8 years | |
| Maria Freire | M | 69 | 6 years | |
| William Reed | M | - |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 11 years |
| Stefan Krauss | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tone Kvåle | F | 55 | 8 years | |
| Roy Hartvig Larsen | M | 62 | 7 years | |
| Malene Brondberg | F | 51 | 5 years | |
| Ludvik Sandnes | M | - | 6 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Kevin Sharer | M | 76 | 20 years | |
| Madhavan Balachandran | M | 73 | 20 years | |
| George Scangos | M | 76 | 24 years | |
| Lowell E. Sears | M | 73 |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 14 years |
| Marc M. P. de Garidel | M | 66 | 15 years | |
| François Martelet | M | 64 | 2 years | |
| John Smither | M | 71 | 6 years | |
| Howard Mayer | M | 62 | 3 years | |
| Karsten Witt | M | 68 | - | |
| Jan Hendrik Egberts | M | 65 | 4 years | |
| Martin Simonetti | M | 66 | 7 years | |
| Stephen Sherwin | M | 75 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | - |
| William Ringo | M | 78 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 2 years |
| Frans Gustaf Wuite | M | 64 | - | |
| Joanna Horobin | M | 69 | 7 years | |
| Jean Bizzari | M | 69 | - | |
| Raju S. Kucherlapati | M | 81 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 12 years |
| Rainer Boehm | M | 63 | 4 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Lars Nieba | M | 56 | - | |
| Ronald Cooper | M | 61 | 5 years | |
| Patricia A. Turney | F | 57 | 23 years | |
| Jacquelyn Sumer | F | 46 | - | |
| Frederick Gluck | M | 88 | 13 years | |
| David Baltimore | M | 86 | 21 years | |
| Fredrik Haavind | M | - | - | |
| Jerry D. Choate | M | 86 | - | |
| Judith C. Pelham | F | 78 | 22 years | |
| Raymond M. Withy | M | 68 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 8 years |
| William Richards | M | 63 | 23 years | |
| Gilbert M. Rishton | M | - | 9 years | |
| Donna French | M | 59 | 15 years | |
| Alan Barge | M | - | 8 years | |
| Daniel Flynn | M | 70 | - | |
| Alex M. DePaoli | M | - | - | |
| Joseph Hagan | M | 55 | 10 years | |
| Anand Varadan | M | 57 | 16 years | |
| Mark Daniels | M | 61 | 21 years | |
| Gary Palmer | M | - | 5 years | |
| Douglas Love | M | 56 | 2 years | |
| David Green | M | - | 11 years | |
| Keith Murphy | M | 52 | 10 years | |
| Andrew Knudten | M | - | 13 years | |
| Aron M. Knickerbocker | M | 54 | 4 years | |
| Urte Gayko | M | 53 | 9 years | |
| David Lacey | M | 71 | 17 years | |
| Henry R. Appelbaum | M | - | 9 years | |
| Wen Chen | M | 56 | - | |
| Yi Ning Zhao | M | 53 | 5 years | |
| Xue Ming Qian | M | 57 | 13 years | |
| Kevin L. Stark | M | - | 15 years | |
| William Marshall | M | 60 | 10 years | |
| Eric Grinstead | M | 66 | 7 years | |
| Stephen Blackwood | M | 61 | 7 years | |
| Roger Jeffs | M | 62 | 3 years | |
| George A. Vandeman | M | 84 | 5 years | |
| Daniel Vapnek | M | 85 | 15 years | |
| Kurt W. Leutzinger | M | 72 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 7 years |
| Mark B. Logan | M | 84 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 9 years |
| Susan Mahony | M | 59 | 4 years | |
| Doug Farrar | M | 59 | 7 years | |
| Wen-Tse Tseng | M | - | 5 years | |
| Larry Alan May | M | 74 | 15 years | |
| John F. Weidenbruch | M | 63 | 10 years | |
| Jeffrey H. Knapp | M | 58 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 1 years |
| Rodney Young | M | 61 |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 4 years |
| Carol Gallagher | M | 59 | 8 years | |
| Margaret E. Valeur-Jensen | M | 67 | 7 years | |
| John G. Adair | M | - | 6 years | |
| Matthew Moyle | M | 63 | 6 years | |
| Brian Lian | M | - | 3 years | |
| Randal A. Hassler | M | 66 | 12 years | |
| Bradley J. Maroni | M | 71 | 6 years | |
| Axel Mescheder | M | - | 2 years | |
| Warren Wayne Myers | M | 62 | 10 years | |
| William D. Welch | M | - | 5 years | |
| Juan Jaen | M | 66 | 10 years | |
| Frederick A. Fletcher | M | - | 10 years | |
| Gregory Stea | M | 66 | 9 years | |
| Carl LeBel | M | 65 | 10 years | |
| Nick Abbott | M | - | 10 years | |
| Richard Yeh | M | 56 | - | |
| Kathleen M. Wiltsey | F | 68 | 14 years | |
| Denny Lanfear | M | 68 | 13 years | |
| Henry Wu | M | - | - | |
| Pirow Bekker | M | 63 | 8 years | |
| Martha E. Vincent | M | - | 9 years | |
| Stephen H. Watkins | M | - | 6 years | |
| David Hallal | M | 57 | 10 years | |
| Jun Yoon | M | 46 |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 87 | 87.00% |
| Norway | 10 | 10.00% |
| Denmark | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gisela Schwab
- Personal Network
